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Obligate intracellular pathogens depend
on cell-surface molecules to attach and
enter into host cells. Pathogen receptors
may be highly specialized proteins, such as
complement receptors or neurotransmitter
receptors, or more ubiquitous components
of cell membranes, such as integrins or
sialic acid–containing oligosaccharides.
The immunoglobulin superfamily (IgSF)
of molecules contains several members
that are expressed at the cell surface, bind
diverse ligands, and contribute to a variety
of cellular activities, including adhesion
and immune responses. Many viruses have
usurped the adhesive properties of IgSF
proteins to mediate attachment (Table 1).
Strategies used by viruses to engage IgSF
receptors provide clues to general mecha-
nisms by which IgSF proteins bind differ-
ent types of ligands, including antigens.
Members of the IgSF have diverged in
sequence and function. However, all
contain domains with the characteristic
immunoglobulin fold, which is defined by
two opposing antiparallel b-sheets con-
nected in a unique manner [1,2]. The core
of the immunoglobulin fold is formed by
four b-strands (B, C, E, and F) augmented
with three to five additional b-strands (A,
C9,C 0, D, and G) to yield several distinct
subtypes [1,2]. Most common are the V-
set and C-set immunoglobulin domains,
which are named according to their
occurrence in the variable and constant
regions of immunoglobulins, respectively.
A third type, the I-set, is an intermediate
structure between the V- and C-sets found
frequently in cell-surface receptors. Immu-
noglobulin domains rarely occur in isola-
tion but typically form concatenated
chains, often with a V-set or I-set domain
at the N-terminus.
Biochemical and structural analyses of
interactions between viruses and their
cognate IgSF receptors reveal several
striking similarities. First, in cases in which
structural information about virus–recep-
tor complexes is available, the viral
attachment proteins exclusively bind to
the most membrane-distal, N-terminal
domain (D1) of the IgSF receptors [3–10].
While structural information about com-
plex formation is lacking for the IgSF
receptors carcinoembryonic antigen-relat-
ed cell adhesion molecule, nectin-1, nec-
tin-2, and signaling lymphocyte-activation
molecule (SLAM), biochemical studies also
implicate their respective D1 domains in
virus binding [11–14]. Second, virus-
contacting residues lie towards the upper
‘‘tip’’ of the IgSF D1 domain. Third, the
viral receptor-binding region engages the
CC9FG b-sheet of the IgSF receptor D1
domain. Fourth and finally, almost all of
the receptor domains interacting with
viruses belong to the V-type IgSF fold.
The single exception, the D1 domain of
ICAM-1, belongs to the I-set type, which
is structurally similar to the V-set domain.
Although the database of viral proteins
in complex with IgSF receptors is still
quite small, interactions of viruses with
their receptors parallel the recognition
mode of immunoglobulins, which also
recognize their cognate antigens via resi-
dues at the tip of their N-terminal, V-set
domains. The case of the receptor-binding
head domain of reovirus attachment
protein s1 in complex with the D1
domain of its receptor, junctional adhesion
molecule-A (JAM-A) [9], serves to illus-
trate this point (Figure 1A). The JAM-A
homodimer strikingly resembles the dimer
formed by the V-set domains of the light
and heavy chains of immunoglobulins. In
both structures, the two V-set domains
face each other with similar orientations.
Moreover, residues in the receptor re-
quired for virus attachment reside in b-
strands and intervening loops that juxta-
pose the complementarity determining
regions (CDRs) of antibody molecules.
Thus, residues known to interact with
ligands map to corresponding regions near
the tip and one side of the V-set domains.
These similarities extend beyond reovirus
receptor JAM-A. Other IgSF virus recep-
tors, such as the coxsackievirus and
adenovirus receptor (CAR) [5] and HIV
receptor CD4 [4], also recognize their
viral ligands via residues that partially
overlap with the CDR region of immuno-
globulins (Figure 1B–F). CAR forms a
homodimer via its D1 domain that is very
similar to the JAM-A homodimer [15].
CD4 also forms homodimers, albeit via its
D4 domain [16].
The immunoglobulin fold predates the
evolution of vertebrates. Genomes of
invertebrate organisms encode numerous
molecules that belong to two families with
homologs in vertebrates: the JAM/cortical
thymocyte marker of Xenopus (CTX) family
and the nectin family [17]. Vertebrate
counterparts of these genes are found in
discrete blocks, and many are now diver-
sified to encode molecules that function in
adaptive immunity, including CD3 and
SLAM [17]. Invertebrates do not encode
recombination-activating genes (RAGs)
and generally display only limited anti-
gen-specific immunity. Therefore, the core
structural element of adaptive immunity,
the immunoglobulin fold, evolved prior to
a mechanism to generate a highly diver-
sified antigen-specific repertoire.
Similarities in mechanisms of ligand
engagement by IgSF pathogen receptors
Citation: Dermody TS, Kirchner E, Guglielmi KM, Stehle T (2009) Immunoglobulin Superfamily Virus Receptors
and the Evolution of Adaptive Immunity. PLoS Pathog 5(11): e1000481. doi:10.1371/journal.ppat.1000481
Editor: Marianne Manchester, The Scripps Research Institute, United States of America
Published November 26, 2009
Copyright:  2009 Dermody et al. This is an open-access article distributed under the terms of the Creative
Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium,
provided the original author and source are credited.
Funding: This work was supported by Public Health Service awards T32 GM08554 (K.M.G.), R37 AI38296
(T.S.D.), and R01 GM67853/AI76983 (T.S.D. and T.S.), and the Elizabeth B. Lamb Center for Pediatric Research.
The funders did not participate in the preparation, review, or approval of the manuscript.
Competing Interests: The authors have declared that no competing interests exist.
* E-mail: terry.dermody@vanderbilt.edu (TSD); thilo.stehle@uni-tuebingen.de (TS)
PLoS Pathogens | www.plospathogens.org 1 November 2009 | Volume 5 | Issue 11 | e1000481and immunoglobulins, coupled with the
evolution of the immunoglobulin fold
prior to the existence of the vertebrate
adaptive immune system, suggest the
possibility that primitive members of the
JAM/CTX and nectin families evolved to
become soluble adaptive immune media-
tors in modern vertebrates. One attractive
hypothesis is that soluble forms of patho-
gen receptors served as precursors to
molecules of the adaptive immune system.
Soluble receptors would neutralize viral
Table 1. IgSF Receptors Used by Selected Viruses.
Virus Receptor Number of Immunoglobulin Domains References
Adenovirus Coxsackievirus and adenovirus receptor (CAR) 2 [31,32]
Coronavirus Carcinoembryonic antigen glycoprotein family (CEACAM) 4 [33–35]
Coxsackievirus B Coxsackievirus and adenovirus receptor (CAR) 2 [31,32]
Herpes simplex virus Nectin-1 (PRR1/HveC) 3 [36]
Nectin-2 (PRR2/HveB) 3 [37]
Human immunodeficiency virus CD4 4 [38,39]
Measles virus Signaling lymphocyte-activation molecule (SLAM) 2 [40]
Poliovirus Poliovirus receptor (PVR, CD155) 3 [41]
Rabies virus Neural cell adhesion molecule (NCAM-1, CD56) 5 [42]
Reovirus Junctional adhesion molecule-A (JAM-A) 2 [28,43]
Rhinovirus Intercellular adhesion molecule-1 (ICAM-1) 5 [44–46]
doi:10.1371/journal.ppat.1000481.t001
Figure 1. Contact areas in Fab and virus receptors. (A) Ribbon drawing of mFab 231 (left) ([27]; 1IGT) and the extracellular domains of hJAM-A
(right) ([28]; 1NBQ). Variable (V) and constant (C) domains of heavy (H) and light (L) chains and D1 and D2 domains of JAM-A are labeled. (B) Ribbon
drawing of the variable domain of the light chain (VL) of the mFab shown in (A). CDRs are colored green. (C–E) Ribbon drawings of the complexed D1
domains of (C) CD4 ([4]; 1GC1), (D) hJAM-A ([9]; 3EOY), and (E) CAR ([5]; 1KAC). Residues contacting the virus proteins with a distance cutoff of 4 A ˚ are
colored green. (F) Structural alignment of mFab 231 VL ([27]; 1IGT), CD4 D1 ([29]; 1CDJ), hJAM-A D1 ([28]; 1NBQ), and CAR D1 ([30]; 1EAJ) performed
using MODELLER (program Web site: http://salilab.org/modeller/). b-strands are indicated, and conserved residues are highlighted in grey. mFab 231
VL CDRs and residues in CD4, hJAM-A, and CAR that contact the viral attachment proteins gp120, s1, and fiber, respectively, with a distance cutoff of
4A ˚, are highlighted in green.
doi:10.1371/journal.ppat.1000481.g001
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pressed versions of the receptor for
binding sites on the virus. In modern
vertebrates, some viruses manipulate sur-
face-expressed and soluble forms of their
receptors to maximize the efficiency of
infection. For example, human rhinovirus
upregulates membrane-bound ICAM-1,
while diminishing expression of the soluble
form of the receptor to increase target cell
infectivity [18]. Expression of a soluble
pathogen receptor followed by duplication
within the primitive genome and acquisi-
tion of mutations that permitted recogni-
tion of additional pathogens could confer a
strong selective advantage. Upon intro-
duction of RAGs into the vertebrate
genome, such a gene family would have
been primed to express molecules akin to
present-day immunoglobulins. Alterna-
tively, membrane-anchored forms of IgSF
molecules that arose in primitive inverte-
brates may have been maintained in the
genome due to their cell-adhesion func-
tions, followed by the serendipitous intro-
duction of mechanisms for the secretion
and generation of diversity. In this scenar-
io, pathogens may have contributed to the
evolution of the modern adaptive immune
system at much later evolutionary times.
Is there evidence that favors either of
these potential evolutionary mechanisms?
In addition to similarities in their ligand-
binding strategies, many of the closest
structural homologs of JAM-A are immu-
noglobulins, which raises the possibility
that immunoglobulins are more closely
related to JAM-A than to other IgSF
molecules. A search for structural homo-
logs of the JAM-A D1 domain using the
Dali algorithm [19] provides support for
this hypothesis. The closest structural
homologs of the JAM-A D1 domain are
immunoglobulin domains, with the high-
est Dali Z-score of 14.6 for an IgAk
variable domain (PDB code 2FBJ)
(Table 2). Other IgSF proteins with
similarity to JAM-A D1 have significantly
lower Z-scores. The Z-scores correlate
well with root mean square deviations for
superpositions of JAM-A D1 with immu-
noglobulins, which also are lower (i.e.,
more similar) than the corresponding
values for superpositions of JAM-A D1
with other IgSF proteins. This homology
search can be extended to CAR, neural
cell adhesion molecule, and nectin-like
molecule 1, which result in Z-scores that
are generally higher for the superposition
of their D1 domains with immunoglobu-
lins than with other cell adhesion mole-
cules. In urochordates (Ciona) and cepha-
lochordates (Branchiostoma), evolutionarily
close relatives of the vertebrates, there
are homologs of JAM/CTX and nectin
IgSF molecules with features of mem-
brane receptors. Ciona encodes only a
single JAM/CTX-like molecule and two
nectin-like molecules [20]. In humans,
these molecules are all part of a single
linkage group involved in immune func-
tion [17,20]. Taken together, these results
suggest that relatively few JAM/CTX and
nectin family IgSF molecules were main-
tained in invertebrates, and the expansion
and duplication resulting in the evolution
of immunoglobulins may have occurred
after the introduction of these molecules
into the vertebrate genome.
There also is evidence of expansion of
IgSF molecules in invertebrates. For
example, like many immunoglobulins,
chitin-binding protein (CBP) of Branchios-
toma is a close structural homolog of JAM-
A (Table 2). Variable region-containing
(V) CBPs contain a V-type immunoglob-
ulin domain with extensive sequence
diversity in the N-terminal region
[21,22]. This diversity is thought to result
from high haplotype variation, including
variable copy number, polymorphisms,
and potential for alternative splicing [23].
Another of the closest structural homologs
of JAM-A is Down syndrome cell adhesion
molecule (Dscam), an IgSF member of the
more evolutionarily distant invertebrate
Drosophila (Table 2). Dscam is an immune
mediator found in clusters of variable
exons flanked by constant exons [24,25].
Thousands of different Dscam molecules
can be generated via alternative splicing, a
mechanism that is highly conserved across
insect orders [26]. Secreted isoforms of
Dscam circulating in insect hemolymph
contribute to phagocytic uptake of bacte-
ria. While the structural similarities be-
tween JAM-A and VCBP or Dscam may
not indicate a direct evolutionary relation-
ship, it is clear that diversification and
secretion of soluble forms of IgSF mole-
cules can occur in invertebrates and raise
the possibility that pathogens have had
selective influence on the diversification
and secretion of these molecules. Thus,
IgSF proteins that served as precursors to
soluble adaptive immune effectors may
have diversified both prior to and follow-
ing their introduction into the vertebrate
genome. A more thorough examination of
IgSF members in invertebrates may clarify
mechanisms that led to the evolution of
modern adaptive immune mediators and
the role of JAM/CTX family molecules in
this evolutionary process.
The evolution of JAM family members
prior to the biochemical means to effi-
ciently and extensively diversify antigen
receptor genes, along with the structural
similarities in the binding surfaces of virus
receptors and immunoglobulins, provides
strong support for the contention that
viruses and perhaps other pathogens that
engage IgSF receptors contributed to the
selection of humoral mediators of adaptive
immunity. These observations provide a
new framework for understanding how
pathogen–host interplay during a pro-
longed period of evolutionary struggle
may have led to the development of
antigen-specific immune responses in
vertebrates.
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Table 2. Dali Search for JAM-A D1 Structural Homologs.
Hit Number Z-score
a r.m.s.d. (A ˚)
b Percent Identical Protein PDB Code-Chain
1–9 24.1–20.3 0.0–0.7 100–65 hJAM-A and mJAM-A
10 14.6 1.8 16 IgA Fab J539 light chain 2FBJ-L
264 13.0 2.4 17 VCBP3 2FBO-J
543 11.7 2.3 22 Dscam 2V5R-A
572 10.5 2.1 19 NCAM 1IE5-A
aA Z-score above ([number of residues/10]–4) is considered significant.
br.m.s.d., root mean square deviation.
doi:10.1371/journal.ppat.1000481.t002
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